LAURIXAMINE
UNII WY0R7196HP

Substance Identification & Data

This profile provides standardized clinical and technical data for Laurixamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WY0R7196HP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 7617-74-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WY0R7196HP

CAS Registry Number

7617-74-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LAURIXAMINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H33NO

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZRJOUVOXPWNFOF-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C80856

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

65596

Unique identification number in the NCBI database of chemical substances.

INN ID

5434

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CCCCCCCCCCCCOCCCN

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Laurixamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.